Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression
- 27 May 2003
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 10 (6) , 457-467
- https://doi.org/10.1038/sj.cgt.7700588
Abstract
Expression of exogenous wild-type (wt) p53 protein can suppress the growth and/or induce apoptosis in different tumor cells. The effect of exogenous p21WAF1/CIP1 expression is more controversial: while it can induce apoptosis in some cells, it can protect against p53-mediated apoptosis in others. We used adenoviral vectors to introduce p53 and p21WAF1/CIP1 genes into human tumor cell lines with different p53 and/or p21WAF1/CIP1 status. The cell growth inhibition and the induction of apoptosis were measured. Overexpression of wt p53 induced more efficient growth inhibition and apoptosis in SW 620 (mutant p53) and HeLa (inactivated p53 protein) than in MCF-7 (wt p53) and CaCo-2 cell line, which was the most resistant to p53 overexpression despite the p53 mutation. Unlike HeLa and SW 620 cells, the basal p21 protein level was readily detected in CaCo-2 and MCF-7 cells. Overexpression of p21WAF1/CIP1 gene induced somewhat less pronounced growth inhibition of all cell lines tested, but it also induced apoptosis in HeLa and SW 620 cells. These results suggest that the basal, but not the inducible, levels of p21WAF1/CIP1 protein in tumor cells could protect from p53-mediated apoptosis. On the other hand, overexpression of p21WAF1/CIP1 gene itself can induce apoptosis in cells with no basal p21WAF1/CIP1 protein level. Possible mechanisms of the differential response to these genes are discussed.Keywords
This publication has 33 references indexed in Scilit:
- p53Cell, 2000
- Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53Cancer Gene Therapy, 2000
- p53-Oriented cancer therapies: Current progressAnnals of Oncology, 1999
- Clinical implications of p53 mutationsCellular and Molecular Life Sciences, 1999
- Studies on the molecular mechanism of growth inhibition with p53 adenoviral construct in human ovarian cancerInternational Journal of Gynecologic Cancer, 1998
- Cytotoxic Effects of Recombinant Adenovirus p53 and Cell Cycle Regulator Genes (p21 sup WAF1/CIP1 and p16 sup CDKN4) in Human Prostate CancersJournal of Urology, 1997
- Gene Therapy for Cancer: What Have We Done and Where Are We Going?JNCI Journal of the National Cancer Institute, 1997
- Molecular Therapy with Recombinant p53 Adenovirus in an Androgen-Independent, Metastatic Human Prostate Cancer ModelHuman Gene Therapy, 1996
- Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilationNucleic Acids Research, 1996
- Tumor Suppressor GenesScience, 1991